308 related articles for article (PubMed ID: 34304366)
1. Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy.
Goodarzi G; Setayesh L; Fadaei R; Khamseh ME; Aliakbari F; Hosseini J; Moradi N
Mol Biol Rep; 2021 Jul; 48(7):5443-5450. PubMed ID: 34304366
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function.
Moradi N; Fadaei R; Khamseh ME; Nobakht A; Rezaei MJ; Aliakbary F; Vatannejad A; Hosseini J
PLoS One; 2019; 14(4):e0215617. PubMed ID: 31009504
[TBL] [Abstract][Full Text] [Related]
3. Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease.
Zhang H; Hu W; Zhang G
Int Urol Nephrol; 2020 Aug; 52(8):1517-1522. PubMed ID: 32458209
[TBL] [Abstract][Full Text] [Related]
4. Effects of GLP-1 receptor agonists on asprosin levels in normal weight or overweight/obesity patients with type 2 diabetes mellitus.
Dai C; Zhu W
Medicine (Baltimore); 2022 Oct; 101(43):e31334. PubMed ID: 36316938
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study.
Moradi N; Fouani FZ; Vatannejad A; Bakhti Arani A; Shahrzad S; Fadaei R
Lipids Health Dis; 2021 Aug; 20(1):88. PubMed ID: 34419063
[TBL] [Abstract][Full Text] [Related]
6. Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy.
Senthilkumar GP; Anithalekshmi MS; Yasir M; Parameswaran S; Packirisamy RM; Bobby Z
Diabetes Metab Syndr; 2018; 12(1):23-26. PubMed ID: 28864059
[TBL] [Abstract][Full Text] [Related]
7. Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin.
Gozel N; Kilinc F
Endokrynol Pol; 2021; 72(1):37-43. PubMed ID: 32944923
[TBL] [Abstract][Full Text] [Related]
8. The relationship of serum asprosin level with diabetic and non-diabetic retinopathy.
Atlı H; Onalan E; Yakar B; Kaymaz T; Duzenci D; Karakulak K; Dönder E; Gürsu MF; Dayanan R
Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2117-2123. PubMed ID: 35363361
[TBL] [Abstract][Full Text] [Related]
9. Serum concentration of asprosin in new-onset type 2 diabetes.
Naiemian S; Naeemipour M; Zarei M; Lari Najafi M; Gohari A; Behroozikhah MR; Heydari H; Miri M
Diabetol Metab Syndr; 2020; 12():65. PubMed ID: 32714446
[TBL] [Abstract][Full Text] [Related]
10. Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease.
Ke F; Xue G; Jiang X; Li F; Lai X; Zhang M; Shen Y; Gao L
Cytokine; 2020 Oct; 134():155184. PubMed ID: 32645536
[TBL] [Abstract][Full Text] [Related]
11. Two Important Players for Type 2 Diabetes Mellitus: Metrnl and Asprosin.
Timurkaan M; Timurkaan ES
Clin Lab; 2022 Sep; 68(9):. PubMed ID: 36125157
[TBL] [Abstract][Full Text] [Related]
12. Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases.
Li X; Liao M; Shen R; Zhang L; Hu H; Wu J; Wang X; Qu H; Guo S; Long M; Zheng H
Mediators Inflamm; 2018; 2018():7375294. PubMed ID: 30524197
[TBL] [Abstract][Full Text] [Related]
13. Association between circulating asprosin levels and carotid atherosclerotic plaque in patients with type 2 diabetes.
Deng X; Zhao Z; Zhao L; Wang C; Li Y; Cai Z; Li H; Gu T; Xia Y; Zhang Z; Wang D; Yang L; Yuan G
Clin Biochem; 2022; 109-110():44-50. PubMed ID: 35961579
[TBL] [Abstract][Full Text] [Related]
14. Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines.
Dadmanesh M; Aghajani H; Fadaei R; Ghorban K
PLoS One; 2018; 13(9):e0204180. PubMed ID: 30212581
[TBL] [Abstract][Full Text] [Related]
15. Asprosin serum levels and glucose homeostasis in children with obesity.
Corica D; Aversa T; Currò M; Tropeano A; Pepe G; Alibrandi A; Ientile R; Wasniewska M
Cytokine; 2021 Jun; 142():155477. PubMed ID: 33662891
[TBL] [Abstract][Full Text] [Related]
16. The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community.
Liang D; Shi G; Xu M; Yin J; Liu Y; Yang J; Xu L
J Diabetes Investig; 2024 May; 15(5):608-613. PubMed ID: 38363189
[TBL] [Abstract][Full Text] [Related]
17. Circulating asprosin, irisin, and abdominal obesity in Chinese patients with type 2 diabetes mellitus: a case-control study.
Hu G; Si W; Zhang Q; Lv F
Endokrynol Pol; 2023; 74(1):55-62. PubMed ID: 36537187
[TBL] [Abstract][Full Text] [Related]
18. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride.
Zhang L; Chen C; Zhou N; Fu Y; Cheng X
Clin Chim Acta; 2019 Feb; 489():183-188. PubMed ID: 29104036
[TBL] [Abstract][Full Text] [Related]
19. Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion.
Wang Y; Qu H; Xiong X; Qiu Y; Liao Y; Chen Y; Zheng Y; Zheng H
Mediators Inflamm; 2018; 2018():9471583. PubMed ID: 29743813
[TBL] [Abstract][Full Text] [Related]
20. Correlation of asprosin and Nrg-4 with type 2 diabetes Mellitus Complicated with Coronary Heart Disease and the Diagnostic Value.
Zhong M; Tian X; Sun Q; Li L; Lu Y; Feng Z; Gao Y; Li S
BMC Endocr Disord; 2023 Mar; 23(1):61. PubMed ID: 36915073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
